4592.T
SanBio Company Limited
グロース · 医薬品 · 医薬品 · JP
JPY 944.00
−0.21%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- -7.9%
- EPS
- -26.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- -5.5%
Three-year CAGR
- Revenue
- —
- EBITDA
- -8.0%
- EBIT
- -7.9%
- Net income
- -33.3%
- EPS
- -25.5%
- Free cash flow
- -5.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jan 1, 2026